Oxycodone News and Research

RSS
New pain management options for patients undergoing knee or hip replacements

New pain management options for patients undergoing knee or hip replacements

QRxPharma announces the initiation of second pivotal Phase 3 registration trial of MoxDuo IR

QRxPharma announces the initiation of second pivotal Phase 3 registration trial of MoxDuo IR

Peripheral nerve stimulation promising for treatment of post-herpetic neuralgia

Peripheral nerve stimulation promising for treatment of post-herpetic neuralgia

Positive results from Phosphagenics' TPM Phase 1B clinical study for transdermal delivery of oxycodone

Positive results from Phosphagenics' TPM Phase 1B clinical study for transdermal delivery of oxycodone

Covidien announces results for first-quarter of fiscal 2010

Covidien announces results for first-quarter of fiscal 2010

Taking opioids long term could hold small risk of addition

Taking opioids long term could hold small risk of addition

New issue from Annals of Internal Medicine

New issue from Annals of Internal Medicine

Study examines how opioid overdose differs by prescribed dose for chronic pain conditions

Study examines how opioid overdose differs by prescribed dose for chronic pain conditions

Safety concerns of acetaminophen

Safety concerns of acetaminophen

Physicians fail to provide pain treatment for fear of prescription drug abuse

Physicians fail to provide pain treatment for fear of prescription drug abuse

FREEDRUGCARD.US launches new Rx savings program to reduce prescription drug prices

FREEDRUGCARD.US launches new Rx savings program to reduce prescription drug prices

Fitch Ratings announces Covidien rating outlook stable

Fitch Ratings announces Covidien rating outlook stable

BDSI's BEMA Buprenorphine Phase 2 study meets primary efficacy endpoint

BDSI's BEMA Buprenorphine Phase 2 study meets primary efficacy endpoint

Deaths from opioid use in Ontario have doubled, according to new study

Deaths from opioid use in Ontario have doubled, according to new study

Phosphagenics commences Phase 1B clinical trial of its oxycodone/TPM transdermal patch systems

Phosphagenics commences Phase 1B clinical trial of its oxycodone/TPM transdermal patch systems

QRxPharma commences Phase 3 pivotal trial of MoxDuo IR

QRxPharma commences Phase 3 pivotal trial of MoxDuo IR

Study examines temporal association between media coverage and opioid-related deaths

Study examines temporal association between media coverage and opioid-related deaths

FDA approves Covidien's Abbreviated New Drug Application for CII

FDA approves Covidien's Abbreviated New Drug Application for CII

36 individuals in Kentucky face federal prescription pill charges

36 individuals in Kentucky face federal prescription pill charges

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.